Nanomaterial Sunscreens Should Be Designated “New Drugs” – Petition
This article was originally published in The Rose Sheet
Executive Summary
FDA should amend the OTC final sunscreen monograph to specify that products containing engineered nanoparticles are excluded and designate the formulas "new drugs," a coalition of public interest groups states in a citizen petition
You may also be interested in...
Nanotech Is “More Than Just Tiny,” Requires FDA Regulation – Lawsuit
A suit filed in U.S. District Court Dec. 21 by coalition of advocacy groups says FDA's failure to respond "meaningfully" to 2006 citizen petition on nanotechnology violates federal law. Lawsuit asks court to order FDA to respond to their peititon without further delay.
Grasping Nanotech Is A Piece Of Cake With Physicist’s “Twinkie Guide”
Andrew Maynard, Ph.D., chief science advisor to the Project on Emerging Nanotechnologies, delivers a lesson on nanotechnology by drawing comparisons to a beloved American snack cake in his video presentation "The Twinkie Guide to Nanotechnology.
Grasping Nanotech Is A Piece Of Cake With Physicist’s “Twinkie Guide”
Andrew Maynard, Ph.D., chief science advisor to the Project on Emerging Nanotechnologies, delivers a lesson on nanotechnology by drawing comparisons to a beloved American snack cake in his video presentation "The Twinkie Guide to Nanotechnology.